This move is archived. Current quotes and coverage live on the stock page.
Follow RKV
Rakovina Therapeutics Inc. shares have taken a significant hit, dropping over 11% in a single trading day.
In the latest trading session, Rakovina Therapeutics Inc (RKV.V) experienced a sharp decline, closing at CA$0.12, down 11.54%. This downturn raises concerns for investors as the company continues to face financial challenges without any recent positive news to bolster investor confidence.
Advertisement
Rakovina Therapeutics Inc
RKV.V
RKV.V
Rakovina Therapeutics Inc
WealthAwesomeMarket cap
$6.23M
52W high
$0.36
52W low
$0.09
1W change
-2.00%
Beta
-0.10
Analyst Price Targets
Based on analyst covering RKV · as of Sep 17, 2026
Wall Street analysts forecast RKV stock price to rise 2.0% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.25
+2.0% Upside
Current Price
C$0.24
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RKV's historical volatility
30-Day Vol
197.2%
Annualized
90-Day Vol
151.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.26 | C$0.13 – C$0.51 |
| 60 trading days | C$0.28 | C$0.11 – C$0.72 |
| 90 trading days | C$0.29 | C$0.09 – C$0.95 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as Rakovina's recent performance reflects ongoing financial struggles, and the lack of positive developments could further impact stock sentiment.
Rakovina's stock tumbles 11.54% in one day.
The market cap now stands at approximately CA$3.17 million, reflecting investor skepticism amidst ongoing losses.
Bull case
If Rakovina can successfully navigate its financial hurdles and leverage its research advancements, there could be potential for recovery in the long term. Investors might see a turnaround if the company can stabilize its finances and deliver promising results from its research initiatives.
Bear case
On the flip side, continued financial losses and a lack of significant news could lead to further declines, making this a risky investment for the foreseeable future. Without any positive developments, investor confidence may continue to erode, impacting the stock's performance.
Advertisement
Recent Performance Overview
Rakovina Therapeutics Inc. has faced a challenging trading day, with shares plummeting by 11.54%. This decline is particularly concerning given the company's current market cap of CA$3.17 million and its ongoing financial losses, including a reported net loss of over $2 million in Q1 2025. Investors are left wondering about the future viability of the company, especially in light of the absence of any recent positive news or developments.
Financial Challenges Ahead
The company's financial reports reveal significant losses, including R&D and G&A expenses that continue to mount. With no recent announcements to counterbalance these losses, investor confidence is waning. The recent share consolidation may also have contributed to the negative sentiment, as it often signals underlying issues within a company. Investors should remain vigilant and consider the risks associated with holding RKV.V shares at this time.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
